• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virulence . Influenza enhances host susceptibility to non-pulmonary invasive Streptococcus pyogenes infections

tetano

Editor, Senior Moderator
Virulence


. 2023 Sep 29;2265063.
doi: 10.1080/21505594.2023.2265063. Online ahead of print. Influenza enhances host susceptibility to non-pulmonary invasive Streptococcus pyogenes infections

Andrea L Herrera[SUP] 1 [/SUP], Rashaun Potts[SUP] 1 [/SUP], Victor C Huber[SUP] 1 [/SUP], Michael S Chaussee[SUP] 1 [/SUP]



Affiliations
Abstract

Streptococcus pyogenes (group A streptococcus; GAS) causes a variety of invasive diseases (iGAS) such as bacteraemia, toxic shock syndrome, and pneumonia, which are associated with high mortality despite the susceptibility of the bacteria to penicillin ex vivo. Epidemiologic studies indicate that respiratory influenza virus infection is associated with an increase in the frequency of iGAS diseases, including those not directly involving the lung. We modified a murine model of influenza A (IAV)-GAS superinfection to determine if viral pneumonia increased the susceptibility of mice subsequently infected with GAS in the peritoneum. The results showed that respiratory IAV infection increased the morbidity (weight loss) of mice infected intraperitoneally (i.p.) with GAS 3, 5, and 10 days after the initial viral infection. Mortality was also significantly increased when mice were infected with GAS 3 and 5 days after pulmonary IAV infection. Increased mortality among mice infected with virus 5 day prior to bacterial infection correlated with increased dissemination of GAS from the peritoneum to the blood, spleen, and lungs. The interval was also associated with a significant increase in the pro-inflammatory cytokines IFN-γ, IL-12, TNF-α, MCP-1 and IL-27 in sera. We conclude, using a murine model, that respiratory influenza virus infection increases the likelihood and severity of systemic iGAS disease, even when GAS infection does not originate in the respiratory tract.

Keywords: Influenza; Streptococcus pyogenes; coinfection; infection model; systemic infection.

 
Back
Top Bottom